Supercharge TB Vaccines: How Molecular Fusion Could Enhance Immunogenicity
Discover how scientists are enhancing TB vaccine effectiveness by fusing the Mycobacterium tuberculosis antigen 85A to the IMX313 adjuvant, boosting immune responses and potentially revolutionizing vaccine design for infectious diseases.